Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 27,859 | $13,967,388 | +22% | 3.76% |
| 2. | Skylands Capital Charles Paquelet | 4,025 | $2,017,974 | +6% | 0.25% |
| 3. | Levin Easterly Partners John Murphy | 4,000 | $2,005,440 | 0.1% | |
| 4. | Lee Munder Capital Group Lee Munder | 2,287 | $1,146,610 | +7% | 0.06% |
| 5. | Sivik Global Healthcare Krishen Sud | 8,000 | $3,932 | 2.99% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $535.93 | 4 | $2,143.73 | 14,268 | 2024-12-09 | Filing | |
| $555.89 | 16 | $8,894.24 | 14,264 | 2024-11-07 | Filing | |
| $526.15 | 4 | $2,104.60 | 13,101 | 2023-06-26 | Filing | |
| $134.16 | 1,000 | $134,160.00 | 14,636 | 2015-12-11 | Filing | |
| $45.84 | 36 | $1,650.24 | 25,914 | 2010-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $462.66 | 400 | $185,064.00 | 25,051 | 2026-04-27 | Filing | |
| $499.40 | 1,607 | $802,535.80 | 20,950 | 2026-03-11 | Filing | |
| $519.74 | 264 | $137,211.36 | 123,925 | 2026-03-05 | Filing | |
| $519.13 | 516 | $267,871.08 | 124,189 | 2026-03-05 | Filing | |
| $517.83 | 106 | $54,889.98 | 124,705 | 2026-03-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,298,760 | $651,146,314 | 0.56% | |
| 2. | 1,005,460 | $504,097,425 | 1.86% | |
| 3. | 593,668 | $297,641,362 | 0.67% | |
| 4. | 577,627 | $289,599,072 | 0.36% | |
| 5. | 514,512 | $257,955,736 | 9.81% |
News See All
What Makes Thermo Fisher Scientific (TMO) an Attractive Long-Term Bet?
Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. A copy of the letter can be downloaded here.
Billionaire Steven Cohen’s Top 11 Dividend Stock Picks
Reuters reported in April that Cohen is making changes to the firm's leadership by passing the title of president to Co-Chief Investment Officer Harry Schwefel.
Is Thermo Fisher Scientific Inc. (TMO) a Top Life Sciences Tools Stock After New Analyst Coverage?
TheFly reported on June 1 that Wolfe Research analyst Mike Polark initiated coverage of TMO with an Outperform rating and set a $535 price target.
10 Best Weight Loss Drug Stocks to Buy in 2026
The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.
14 Best S&P 500 Stocks to Buy Now According to Analysts
As of the writing of this piece, the S&P 500 index has surged by 8.35% since the beginning of 2026.
Billionaire Ken Fisher’s Top 11 Dividend Stock Picks
In a recent episode of the Market Insights podcast, Fisher Investments Founder, Executive Chairman, and Co-Chief Investment Officer Ken Fisher addressed a new set of listener questions.
Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating?
TheFly reported on May 14 that RBC Capital restarted coverage of TMO with a Sector Perform rating and assigned a $490 price objective.
10 Most Widely Held Stocks by Individuals in 2026
Despite continuous global unrest, strong corporate profits are boosting market confidence.
11 Best Medical Technology Stocks to Buy Right Now
One of the key conclusions in EY’s 19th annual Pulse of the MedTech Industry Report is that the global medical technology market has moved from a period of post-pandemic turbulence into one of durable...
Hedge Fund Resource Center